Show
Sort by
-
- Journal Article
- A1
- open access
Health-related quality of life outcomes of salvage metastasis-directed treatment versus elective nodal treatment for oligorecurrent nodal prostate cancer : a secondary analysis of the phase 2, open-label PEACE V–STORM randomized trial
-
- Journal Article
- A1
- open access
Update of the EORTC health-related quality of life modules for bladder cancer : phase 1–2 of the development process
-
- Journal Article
- A1
- open access
Genomic determinants associated with modes of progression and patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer
-
- Journal Article
- A1
- open access
Stage migration on prostate-specific membrane antigen positron emission tomography/computed tomography in comparison to conventional imaging in patients with high-risk prostate cancer referred for radiation therapy : results from the phase 2/3 THUNDER trial
-
- Journal Article
- A1
- open access
Prognostic value of the circulating tumor DNA fraction in metastatic castration-resistant prostate cancer : results from the ProBio platform trial
-
- Journal Article
- A1
- open access
Challenges in follow-up after kidney-sparing surgery for upper tract urot helial carcinoma : insights from a Delphi consensus
-
PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial
-
- Journal Article
- A1
- open access
Olaparib plus abiraterone for metastatic castration-resistant prostate cancer : pharmacokinetics data from the PROpel trial
-
Review of prospective trials assessing the role of stereotactic body radiation therapy for metastasis-directed treatment in oligometastatic genitourinary cancers
-
A urine-based genomic assay improves risk stratification for patients with high-risk hematuria stratified according to the American Urological Association guidelines